Arab Israeli Conflict
Middle East News
Hi Tech News
The new treatment "gets the immune troops 'ready for combat,' in both the brain and the rest of the body."
Hope is that successful trials will allow Rafael Pharmaceuticals will receive expedited FDA approval by late 2020.
These membrane proteins could provide a target for new treatments.
Please insert a valid email address